Adoption of clinical decision support (CDS) systems—which deliver critical information to providers at the point of care—are positioned to overtake electronic health records (EHRs) as the primary health IT tool, a new study says.
Research and consulting firm Frost & Sullivan, which released the report “U.S. Clinical Decision Support Systems Market, Forecast to 2024,” contends that over the forecast period, CDS will be used as an essential bridge between EHRs and the clinical workflow.
Unlike EHR systems that are primarily a way for physicians to document treatment protocols, CDS applications are designed to provide support for physicians during interactions with patients.
The report analyzes the latest trends, regulatory changes, and forecasts market growth in clinical knowledge and medical evidence, healthcare analytics, workflow solutions, EHRs, medical devices, data support, clinical surveillance, and clinical decision support platforms.
The market is forecast to grow from $3.79 billion in 2018 to $6.4 billion in 2024, at a compound annual growth rate of 9.3%. The report attributes this to CDS becoming a critical component of healthcare delivery as well as regulatory compliance.
Other significant growth opportunities include:
- Making systems interoperable.
- Extending services to cover population health to improve patient outcomes and augment the role of clinical data in driving success.
- Studying results of in-place clinical surveillance systems and evaluating the potential to create measurable value propositions.
“With the delivery of healthcare becoming more complex, there is an urgent need for a superior user interface, both to reduce the load on the physician, as well as ensure that the physician is informed of the latest treatment options and protocols,” said Mike Jude, research manager, digital health, at Frost & Sullivan. “The trend towards more regulatory oversight and the adoption of new information technology will further drive the need for clinical decision support.”